COAGULATION CATASTROPHIES: TAKING CARE OF THE MOST DIFFICULT CASES IN EMERGENCY MEDICINE

COAGULATION CATASTROPHIES: TAKING CARE OF THE MOST DIFFICULT CASES IN EMERGENCY MEDICINE

This monograph covers advances in cardiac biomarker diagnostics including high-sensitivity troponin assays and CT coronary angiography, novel anticoagulant therapy, advances in antiplatelet therapy which have been incorporated into the latest ACCF/AHA guidelines, the interventional cardiologists perspective, and novel diagnostics for determining a patient’s clotting status by thromboelastography.

Read More

HEART FAILURE: BIOMARKERS OF DIAGNOSIS AND PROGNOSIS

HEART FAILURE: BIOMARKERS OF DIAGNOSIS AND PROGNOSIS

Heart Failure remains a common presentation in the emergency department. For the emergency physician clarifying the course of the universal complaint, shortness of breath, requires excellent clinical acumen combined with a clear understanding of the laboratory tests available to distinguish Heart Failure from other causes of dyspnea. Dr. Frank Peacock of the Cleveland Clinic authors an excellent discussion of the scientific basis for the use of the natriuretic peptide biomarkers in heart failure including future markers currently being investigated.

Read More

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2006)

ADVANCING THE STANDARD OF CARE - CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES (2006)

EMCREG–International is pleased to present this complimentary 84-page CME monograph covering the proceedings of our satellite symposium at the ACEP Scientific Assembly in New Orleans, Louisiana. A number of important topics are covered in this monograph including management of non-ST-segment elevation and ST-segment elevation acute coronary syndrome (ACS), the CRUSADE Quality Improvement Initiative, decreasing time to treatment for ST-segment elevation myocardial infarction, direct thrombin inhibitors in ACS, acute decompensated heart failure care, the use of lactate as a marker for trauma and sepsis, point-of-care testing for cardiac biomarkers, the management of hypertension in acute neurovascular emergencies and advances in acute stroke care.

Read More

CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES AND POINT-OF-CARE TESTING

CARDIOVASCULAR AND NEUROVASCULAR EMERGENCIES AND POINT-OF-CARE TESTING

The Emergency Medicine Cardiac Research and Education Group (EMCREG)-International is pleased to present this monograph representing the proceedings of our satellite symposium at the ACEP Scientific Assembly in Washington, DC, in late September of 2005. In this monograph, you will find a variety of important topics covered including the CRUSADE Quality Improvement Initiative, clopidogrel’s use in ST-segment elevation myocardial infarction, low molecular weight heparins in acute coronary syndromes, dyslipidemia, diagnosis and treatment on acute decompensated heart failure, evaluation of pulmonary embolism, cardiac biomarkers in point-of-care testing, the Stroke Center certification concept, evaluation of transient ischemic attacks, and the role of serum biomarkers in the diagnosis of stroke.

Read More

THE FUTURE OF CARDIAC BIOMARKERS

THE FUTURE OF CARDIAC BIOMARKERS

In this EMCREG-International newsletter, Judd E. Hollander, MD, from the Hospital of the University of Pennsylvania, discusses the development and current emergency department use of cardiac necrosis biomarkers (CK-MB, troponin, myoglobin), biomarkers of inflammation (C-reactive protein), and newer cardiac biomarkers of myocardial ischemia (brain natriuretic peptide). It is our hope to provide emergency physicians with a better understanding of the cardiac biomarkers used in emergency practice for diagnosis of ACS.

Read More